CASI PHARMACEUTICALS, INC. Inventory Write-down
CASI PHARMACEUTICALS, INC. (CASIF) reported Inventory Write-down of $1.15 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-05-15
| Period end | Inventory Write-down 12 month |
|---|---|
| 2025-12-31 | $1.15M 20-F · filed 2026-05-15 |
| 2024-12-31 | $4.80M 20-F · filed 2026-05-15 |
| 2023-12-31 | $0.00 20-F · filed 2026-05-15 |
| 2022-12-31 | $0.00 20-F · filed 2025-03-31 |
| 2021-12-31 | $0.00 20-F · filed 2024-03-28 |
| 2020-12-31 | $0.00 20-F · filed 2023-04-26 |